Replies to post #76498 on Ayala Pharmaceuticals Inc (ADXS)

[hovacre]

Merck, BMY, and Roche are all major players in the NSCLC space. Merck has been the most successful as of late, so I could see it swinging either to Merck or BMY, if that's how it's going to go. Merck would want to solidify its lead. BMY would want a chance to claw back more of its market share, since they just fell behind Merck in sales for the first time